PGC1α overexpression preserves muscle mass and function in cisplatin‐induced cachexia
Abstract Background Chemotherapy induces a cachectic‐like phenotype, accompanied by skeletal muscle wasting, weakness and mitochondrial dysfunction. Peroxisome proliferator‐activated receptor‐gamma coactivator‐1 alpha (PGC1α), a regulator of mitochondrial biogenesis, is often reduced in cachectic sk...
Main Authors: | Joshua R. Huot, Fabrizio Pin, Rohit Chatterjee, Andrea Bonetto |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-10-01
|
Series: | Journal of Cachexia, Sarcopenia and Muscle |
Subjects: | |
Online Access: | https://doi.org/10.1002/jcsm.13035 |
Similar Items
-
Mitochondrial Dysfunction in Cancer Cachexia: Impact on Muscle Health and Regeneration
by: Marc Beltrà, et al.
Published: (2021-11-01) -
Chemotherapy‐induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol
by: Daniel I. Brierley, et al.
Published: (2019-08-01) -
Sustained PGC-1α2 or PGC-1α3 expression induces astrocyte dysfunction and degeneration
by: M.J. Nunes, et al.
Published: (2024-03-01) -
Exercise-induced PGC-1α transcriptional factors in skeletal muscle
by: Suryun Jung, et al.
Published: (2014-12-01) -
HCT116 colorectal liver metastases exacerbate muscle wasting in a mouse model for the study of colorectal cancer cachexia
by: Joshua R. Huot, et al.
Published: (2020-01-01)